John Naim, PhD Director Clinical Trials Research Unit

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

What FDA Looks for When Inspecting IRBs and Sponsors Marian J. Serge Nurse Consultant Division of Bioresearch Monitoring Office of Compliance Center for.
Tips to a Successful Monitoring Visit
The Radioactive Drug Research Committee Approval Process for Tracer Use Anthony F. Shields, M.D., Ph.D. Karmanos Cancer Institute Wayne State University.
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
What is involved? What are your responsibilities? May 2013: Research Institute, Clinical Research Administration Investigational New Drug Application (IND)
The IND and Clinical Trial Management Frances Richmond Director International Center for Clinical Trials.
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
The Consent Process: It’s More Than Just a Form A “10 Minute Training” Brought to you by Cyndi Long, MS, RD, CCRC CU Sports Medicine.
Introduction to GCP and 21CFR312. Dear Clinical Investigator…
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
IRB-Investigator/ Research Coordinator Mtg. “CUMC’s New Progressive Policy For Adverse Event Reporting” April 13, 2004 George Gasparis Andrew Wit, Ph.D.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami and Affiliated Institutions.
Overview of Good Clinical Practices (GCPs)
Federalwide Assurance Presentation for IRB Members.
Good Clinical Practice GCP overview
THE UNIVERSITY OF NEW MEXICO ▪ HEALTH SCIENCES CENTER Clinical and Translational Science Center (CTSC) 4/2009.
Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.
Janet Ellen Holwell, CCRC, CCRA President, NY Metropolitan Chapter of ACRP.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
Fundamentals of ICH and GCP
Investigational New Drug Application (IND)
Introduction to GCP and 21CFR312. Highly Regulated Profession We’ve already got the NRC and CRCPD We’ve already got wipe tests and calibrations and phantoms.
INDs : Does My Study Need One? Edith Paal UAMS Office of Research Compliance August 22, 2003.
HUMAN RESEARCH HISTORICAL PERSPECTIVE. Objectives Identify the history events that lead to the development of principles, regulations, and guidance.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
© 2009 Cengage Learning. All Rights Reserved. Clinical Research.
PATRICIA KERBY, MPA HUMAN SUBJECTIONS PROTECTION COMPLIANCE OFFICER OFFICE OF RESEARCH COMPLIANCE What are the FDA’s expectations in 2010?
Read the SMALL PRINT of the 1572 The Essential GCP Document.
TERRENCE F. ACKERMAN, PH.D. PROFESSOR OF BIOETHICS CHAIR, UTHSC IRB.
1 Denise K. Thwing, MAS, RN, CCRA March 31, 2010 Version: Final 31-Mar-2010.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
Copyright FDA Inspections: Where Do Things Go Wrong? Diana Naser RN, MS, CCRP Executive Director Clinical Research Administration Clinical Research.
Investigational Devices and Humanitarian Use Devices June 2007.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Office of Human Research Protection Georgia Health Sciences University.
INVESTIGATOR RESPONSIBILITIES C. Karen Jeans, MSN COACH Project Analyst.
Chapter 5 Ethical Concerns in Research. Historical Perspective on Ethics Nazi Experimentation in WWII –“medical experiments” –Nuremberg War Crime Trials.
Role of Site Investigator Ensure subject safety is protected & well-managed Full compliance with requirements of Good Clinical Practice (GCP) Conduct the.
PRIMER: Human Subjects, Past, Present, and Future Susan Metosky, Arizona State University Debra Murphy, Arizona State University.
FDA Draft Guidance on the Form FDA and Other Updates David A. Lepay, M.D., Ph.D. Senior Advisor for Clinical Science, U.S. FDA DIA GCP All-SIAC.
INVESTIGATOR RESPONSIBILITIES April Objectives Review and Discuss:  Responsibilities of the clinical research Investigator as per relevant regulations.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
GCP (GOOD CLINICAL PRACTISE)
Responsibilities of Sponsor, Investigator and Monitor
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
Supervisory Responsibilities of Clinical Investigators
Good Clinical Practice (GCP) and Monitoring Practices
Responsibilities of Sponsor, Investigator and Monitor
Investigator-initiated Research What Are your Responsibilities?
FDA’s IDE Decisions and Communications
How to Put Together an IDE Application
Adverse Event Reporting: Trials and Tribulations
Investigator Responsibilities in Human Subjects Research
UK Legal Requirement for Notification of Serious Breaches of Good Clinical Practice or The Trial Protocol John Poland, PhD Senior Director, Regulatory.
Roles and Responsibilities of the Clinical Research Team
Elements of an Organized Regulatory Binder
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Understanding the Process of Documenting Informed Consent
Good clinical practice
Presentation transcript:

SoCRA Review: Investigator Roles and Responsibilities in Clinical Research John Naim, PhD Director Clinical Trials Research Unit West Virginia University March 20, 2015

Outline Historical Perspective Legal Framework Clinical Investigator Roles and Responsibilities GCP Q & A Discussion West Virginia Clinical and Translational Science Institute

Disclaimer Information from: FDA Clinical Investigator Training Course http://www.fda.gov/downloads/Training/ClinicalInvestigatorTrainingCourse/UCM378565.pdf GCP questions from Paul Below presentation: http://www.slideshare.net/PaulBelow/so-you-think-you-know-gcp-mar-2013 West Virginia Clinical and Translational Science Institute

Historical Perspective Past transgressions lead to the need for laws that protect the rights and welfare of human subjects. Nuremberg Doctors Trial of 1946 (Nuremberg Code) Thalidomide Tragedy (Kefauver-Harris Amendment) Tuskegee Experiments (Belmont Report) Human Radiation Experiments Gene Transfer Experiment West Virginia Clinical and Translational Science Institute

Historical Perspective Past transgressions lead to the need for laws that protect the rights and welfare of human subjects. Nuremberg Doctors Trial of 1946 (Nuremberg Code) Thalidomide Tragedy (Kefauver-Harris Amendment) Tuskegee Experiments (Belmont Report) Human Radiation Experiments Gene Transfer Experiment The public trust is sine qua non of clinical research West Virginia Clinical and Translational Science Institute

Legal Framework Federal Food, Drug, and Cosmetic Act (FD&C Act) Section 505(i) is the statutory authority for FDA’s oversight of clinical investigations to test safety and effectiveness Code of Federal Regulations (CFR) Regulations promulgated under Section 505(i) describing FDA’s authority over the conduct of clinical investigations including -Sponsor Responsibilities -Clinical Investigator Responsibilities Guidance – advisory only, to assist clinical investigators and sponsors in complying with the regulations FDA Form 1572 – by signing this form, an investigator agrees to conduct a study in accordance with the protocol and applicable regulations and to provide adequate supervision of a study West Virginia Clinical and Translational Science Institute

Legal Framework (cont.) Good Clinical Practice (GCP): A standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate, and that the rights, integrity, and confidentiality of trial subjects are protected. West Virginia Clinical and Translational Science Institute

The Clinical Investigator An individual who actually conducts a study (i.e. under whose immediate direction the drug is dispensed to a subject.) In the event an investigation is conducted by a team of individuals, the investigator is the responsible leader of the team. [21 CFR 312.3] West Virginia Clinical and Translational Science Institute

Investigator Roles Good Clinical Practice (GCP) in FDA‐regulated research is not the same as good clinical practice in caring for patients For example, FDA regulations have very specific requirements for following the protocol, recordkeeping, and drug accountability Regulations are designed to: -Ensure the quality and integrity of data collected in clinical trials -Ensure that the rights, safety and welfare of research participants are protected West Virginia Clinical and Translational Science Institute

Commitments on Form 1572 Personally conduct or supervise investigation Follow protocol Ensure all persons assisting is study are informed of obligations Inform subjects that drugs are being used for investigational purposes Ensure informed consent (21 CFR Part 50) and IRB review, approval and reporting (21 CFR Part 56) Report to sponsor adverse events (21 CFR 312.64) Maintain adequate and accurate records and make them available for inspection in accordance with 21 CFR 312.68 Ensure initial and continuing review by an IRB and report all changes to research and unanticipated problems involving risks to subjects, not make any changes without IRB approval except where necessary to eliminate immediate hazards Comply with other requirements in 21 CFR 312 West Virginia Clinical and Translational Science Institute

Frequently Asked Questions Form 1572 Why does this form need to be completed by an investigator? West Virginia Clinical and Translational Science Institute

Frequently Asked Questions Form 1572 Why does this form need to be completed by an investigator? 1) To provide the sponsor with information about the investigator’s qualifications and clinical site. 2) To inform the investigator of his/her obligations and obtain the investigator’s commitment to follow pertinent FDA regulations. Making willfully false statement is a criminal offense. West Virginia Clinical and Translational Science Institute

Frequently Asked Questions Form 1572 Does the 1572 need to be submitted to FDA? West Virginia Clinical and Translational Science Institute

Frequently Asked Questions Form 1572 Does the 1572 need to be submitted to FDA? No. Although the sponsor is required to collect 1572 from the investigator, FDA does not require the form to be submitted to the agency. West Virginia Clinical and Translational Science Institute

Frequently Asked Questions Form 1572 Are CVs required to be signed and dated? West Virginia Clinical and Translational Science Institute

Frequently Asked Questions Form 1572 Are CVs required to be signed and dated? No. FDA regulations do not require a CV to be signed and dated. The investigator’s dated signature on the 1572 is sufficient to attest to the accuracy of the CV or other statement of qualifications submitted. West Virginia Clinical and Translational Science Institute

Investigator Responsibilities General responsibilities (312.60) Control of investigational drug (312.61) Record keeping and retention (312.62) Maintaining adequate records of the disposition of the drug Accurate case histories that record all observations, and Other data pertinent to the investigation on each individual administered the investigational drug or employed as a control in the investigation An investigator is required to maintain investigation records for: 2 years following the data a marketing application is approved for the drug for the indication for which it is being investigated 2 years after the investigation is discontinued and FDA is notified if no application is to be filed or if the application has not approved for such indication West Virginia Clinical and Translational Science Institute

Investigator Responsibilities (cont.) Investigator reports (312.64) Progress reports Safety reports Promptly report any adverse event that may reasonably be regarded as caused by, or probably caused by, the drug (err on the side of reporting) Immediately report any adverse event that is alarming (e.g. an unexpected event that is serious or life‐threatening) Final report Financial disclosure West Virginia Clinical and Translational Science Institute

FDA Guidance Investigator Responsibilities Outlines FDA expectations for study oversight Appropriate delegation of study tasks Appropriate training of study staff Appropriate supervision of conduct of ongoing study Appropriate oversight of third parties involved in the study (e.g. Site Management Organizations, outside labs specifically retained to conduct study assessments) West Virginia Clinical and Translational Science Institute

FDA Guidance Investigator Responsibilities (Cont.) Outlines FDA expectations for protecting the rights, safety, and welfare of subjects Provision of reasonable medical care for issues related to study participation (e.g.to manage an adverse event) Facilitation of care for other health issues that might arise during the study Avoiding exposure of subjects to unreasonable risks West Virginia Clinical and Translational Science Institute

Ready for some GCP Questions? West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

West Virginia Clinical and Translational Science Institute

Questions? Thank You www.wvctsi.org Made possible by IDeA CTR support – NIH/NIGMS Award Number U54GM104942 West Virginia Clinical and Translational Science Institute